Matthijs Moerland Selected Research

Matthijs Moerland Research Topics

Disease

9	Inflammation (Inflammations) 05/2024 - 07/2008
8	Atherosclerosis 10/2009 - 09/2006
7	Erythema 01/2024 - 11/2018
5	Necrosis 05/2024 - 10/2013
4	Blister (Bulla) 05/2024 - 01/2022
4	Thrombosis (Thrombus) 12/2022 - 02/2003
3	Parkinson Disease (Parkinson's Disease) 01/2023 - 01/2022
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 01/2020
2	Body Weight (Weight, Body) 01/2023 - 01/2022
2	Endotoxemia 09/2022 - 01/2018
2	Headache (Headaches) 01/2022 - 01/2021
2	COVID-19 01/2021 - 01/2021
2	Sleepiness 01/2021 - 08/2012
2	Acute Kidney Injury (Acute Renal Failure) 01/2018 - 10/2013
2	Type 2 Diabetes Mellitus (MODY) 01/2017 - 11/2016
2	Coronary Artery Disease (Coronary Atherosclerosis) 12/2016 - 04/2016
2	Injection Site Reaction 01/2016 - 12/2015
2	Atherosclerotic Plaque (Atheroma) 12/2011 - 03/2010
2	Rupture 12/2011 - 03/2010
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2023
1	Intestinal Failure 01/2023
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Hyperemia 01/2023
1	Movement Disorders (Movement Disorder) 01/2023
1	Short Bowel Syndrome 01/2023
1	Sepsis (Septicemia) 12/2022
1	Infections 09/2022
1	Leukopenia 01/2022
1	Dysbiosis 01/2022
1	Syncope (Fainting) 01/2022
1	Asthenia 01/2022
1	Atopic Dermatitis (Atopic Eczema) 01/2022
1	Cystinosis 01/2021
1	Dizziness (Lightheadedness) 01/2021
1	Hypersensitivity (Allergy) 01/2021
1	Major Depressive Disorder (Major Depressive Disorders) 01/2021
1	Nasopharyngitis 01/2021
1	Phlebitis 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2020
1	Thrombophilia 08/2020
1	Hemorrhage 07/2020

Drug/Important Bio-Agent (IBA)

6	CytokinesIBA 05/2024 - 01/2020
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2018
5	Imiquimod (Aldara)FDA LinkGeneric 05/2024 - 11/2018
5	Lipoproteins (Lipoprotein)IBA 12/2016 - 09/2006
4	Interleukin-8 (Interleukin 8)IBA 05/2024 - 01/2022
4	Phospholipid Transfer ProteinsIBA 10/2009 - 09/2006
3	Interleukin-6 (Interleukin 6)IBA 05/2024 - 12/2022
3	Prednisolone (Predate)FDA LinkGeneric 01/2024 - 01/2022
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2023 - 01/2021
3	LDL Receptors (LDL Receptor)IBA 07/2008 - 12/2007
2	InterferonsIBA 05/2024 - 01/2022
2	Interleukin-10 (Interleukin 10)IBA 05/2024 - 01/2022
2	InterleukinsIBA 05/2024 - 01/2022
2	Glucosylceramidase (Glucocerebrosidase)IBA 01/2023 - 01/2023
2	Immunoglobulin G (IgG)IBA 01/2022 - 01/2021
2	Antimicrobial PeptidesIBA 01/2022 - 01/2020
2	OmigananIBA 01/2022 - 01/2020
2	Huntingtin ProteinIBA 01/2021 - 01/2020
2	VaccinesIBA 10/2020 - 01/2020
2	MDCO-216IBA 12/2016 - 04/2016
2	LipidsIBA 12/2016 - 09/2006
2	CholesterolIBA 04/2016 - 06/2009
2	HDL LipoproteinsIBA 04/2016 - 09/2006
2	OligonucleotidesIBA 01/2016 - 10/2013
2	CreatinineIBA 12/2015 - 10/2013
1	zabedosertibIBA 01/2024
1	Glucagon (Glukagon)FDA Link 01/2023
1	Glucosylceramides (Glucocerebrosides)IBA 01/2023
1	GlycosphingolipidsIBA 01/2023
1	HydrogenIBA 01/2023
1	NAD (NADH)IBA 01/2023
1	CDw17 antigen (lactosylceramide)IBA 01/2023
1	apraglutideIBA 01/2023
1	Toll-Like Receptor 7IBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2022
1	C-Reactive ProteinIBA 12/2022
1	Thromboplastin (Tissue Factor)IBA 12/2022
1	Toll-Like Receptor 4IBA 12/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	LipopolysaccharidesIBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	EnzymesIBA 01/2022
1	SynucleinsIBA 01/2022
1	Clobetasol (Clobetasol Propionate)FDA LinkGeneric 01/2022
1	Immunoglobulin M (IgM)IBA 01/2021
1	Delayed-Action PreparationsIBA 01/2021
1	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 01/2021
1	Cysteamine (Mercaptamine)FDA Link 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	Antidepressive Agents (Antidepressants)IBA 01/2021
1	E-SelectinIBA 08/2020
1	Erythropoietin FDA Link 08/2020
1	SugammadexIBA 07/2020

Therapy/Procedure

8	Therapeutics 01/2023 - 10/2013
2	Lasers (Laser) 01/2024 - 01/2020
1	Immunomodulation 05/2024
1	Oral Administration 01/2023
1	Topical Administration 01/2022
1	Catheters 01/2021